Virpax Pharmaceuticals, Inc. - stock earnings
VRPX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.0 million USD | ? USD |
| 2023Q2 | -3.1 million USD | ? USD |
| 2023Q1 | -1.4 million USD | ? USD |
| 2022Q4 | -2.9 million USD | ? USD |
| 2022Q3 | -7.6 million USD | ? USD |
| 2022Q2 | -5.9 million USD | ? USD |
| 2022Q1 | -5.2 million USD | ? USD |
| 2021Q4 | -4.1 million USD | ? USD |
| 2021Q3 | -3.2 million USD | ? USD |
| 2021Q2 | -2.3 million USD | ? USD |
| 2021Q1 | -2.4 million USD | ? USD |
| 2020Q4 | -705211 USD | ? USD |
| 2020Q3 | -1.7 million USD | ? USD |
| 2020Q2 | -1.3 million USD | ? USD |
| 2020Q1 | -656495 USD | ? USD |
| 2019Q4 | -700013 USD | ? USD |
VRPX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.6 million USD | ? USD |
| 2022 | -21.5 million USD | ? USD |
| 2021 | -12.1 million USD | ? USD |
| 2020 | -4.5 million USD | ? USD |
| 2019 | -3.4 million USD | ? USD |
| 2018 | -2.6 million USD | ? USD |
VRPX
Price: $3.10
52 week price:
Earnings Per Share: -12.97 USD
P/E Ratio: -0.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 123600
Market Capitalization: 4.2 million